VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $266,955,000 | +12.3% | 2,025 | 0.0% | 0.07% | +7.7% |
| Q4 2013 | $237,735,000 | +12.5% | 2,025 | 0.0% | 0.06% | +3.2% |
| Q3 2013 | $211,268,000 | -63.6% | 2,025 | -70.0% | 0.06% | -65.6% |
| Q2 2013 | $580,179,000 | +5.2% | 6,740 | -8.3% | 0.18% | -1.1% |
| Q1 2013 | $551,397,000 | +25.5% | 7,350 | 0.0% | 0.18% | +4.5% |
| Q4 2012 | $439,309,000 | – | 7,350 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |